Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis
BCT-OS shows promise as an alternative treatment for psoriasis, offering localized therapeutic benefits with a potentially improved safety profile compared to systemic administration.
Authors
- Lupe Carolina Espinoza (ORCID: https://orcid.org/0000-0003-1486-5622)
- María J. Rodríguez-Lagunas (ORCID: https://orcid.org/0000-0001-7870-8250)
- Núria Garrós (ORCID: https://orcid.org/0000-0003-2571-2066)
- Lilian Sosa (ORCID: https://orcid.org/0000-0001-8148-9482)
- Mireia Mallandrich (ORCID: https://orcid.org/0000-0001-9316-8459)
- Joaquim Suñer‐Carbó (ORCID: https://orcid.org/0000-0002-9238-187X)
- Roya Mohammadi-Meyabadi (ORCID: https://orcid.org/0000-0003-4799-6362)
- Marı́a Luisa Garduño-Ramı́rez (ORCID: https://orcid.org/0000-0001-5041-5587)
- Ana Cristina Calpena (ORCID: https://orcid.org/0000-0002-4989-4821)
- Negar Beirampour
Institutions
- Universidad Técnica Particular de Loja (EC)
- National Autonomous University of Honduras (HN)
- Institute of Agrifood Research and Technology (ES)
- Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona
- Universitat de Barcelona (ES)
- Universidad Autónoma del Estado de Morelos (MX)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3390/pharmaceutics16101287
- Citations
- 7
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Universidad Nacional Autonoma de Honduras